Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Legend Biotech (LEGN) Research & Development (2019 - 2025)

Legend Biotech filings provide 7 years of Research & Development readings, the most recent being -$101.3 million for Q4 2025.

  • On a quarterly basis, Research & Development rose 2.97% to -$101.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$414.7 million, a 0.28% change, with the full-year FY2025 number at -$414.7 million, changed 0.29% from a year prior.
  • Research & Development hit -$101.3 million in Q4 2025 for Legend Biotech, up from -$113.1 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of -$71072.0 in Q1 2021 to a low of -$113.1 million in Q3 2025.
  • Median Research & Development over the past 5 years was -$95.7 million (2023), compared with a mean of -$84.1 million.
  • Biggest five-year swings in Research & Development: tumbled 114639.98% in 2022 and later soared 99.87% in 2023.
  • Legend Biotech's Research & Development stood at -$86.5 million in 2021, then increased by 6.64% to -$80.8 million in 2022, then soared by 99.87% to -$105683.0 in 2023, then crashed by 98685.99% to -$104.4 million in 2024, then grew by 2.97% to -$101.3 million in 2025.
  • The last three reported values for Research & Development were -$101.3 million (Q4 2025), -$113.1 million (Q3 2025), and -$98.3 million (Q2 2025) per Business Quant data.